SEVERE ACUTE MALNUTRITION: A RANDOMIZED CONTROLLED STUDY IN UGANDA Benedikte Grenov, yHanifa Namusoke, yBetty Lanyero, yNicolette Nabukeera- Barungi, Christian Ritz, Christian Molgaard, Henrik Friis, and Kim F. Michaelsen
Ni Wayan Dwi Novita
17360065
Preseptor: dr. Aspri Sulanto, Sp.A BACKGROUND
Severe acute malnutrition (SAM) is a major challenge
in low income countries and results in 0.5 to 1 million child deaths annually.
Diarrhea is a major complication to SAM associated
with increased morbidity, longer hospitalization, and death OBJECTIVES
The aim of the study was to assess the effect of
probiotics on diarrhea during in- and outpatient treatment of children with severe acute malnutrition (SAM). METHODS Mwanamugimu Nutrition Unit (MNU), Department of Pediatrics and Child Health, Mulago National Referral Hospital, Kampala, Uganda
• 400 children admitted with SAM
• Patients received 1 daily dose of a blend of Bifidobacterium animalis subsp lactis and Lactobacillus rhamnosus (10 billion colony-forming units, 50:50) or placebo during hospitalization followed by an 8 to 12 week outpatient treatment period, depending on patients’ recovery rate • Analyzed using statistical software R version 3.1.1 HASIL RESULTS DISKUSI DISKUSI RESULTS There was no difference in number of days with diarrhea between the probiotic (n=200) and placebo (n=200) groups during inpatient treatment (P=0.69); however, during outpatient treatment, probiotics reduced days with diarrhea (P=0.025). Number of patients that died in the probiotic group (26 patients) compared with the placebo group (20 patients). DISCUSSION The mortality reports showed multiple severe medical complications in most of the children, complicating assessment of the exact cause of death. The most common causes of death, according to the mortality reports, were respiratory failure/severe pneumonia and shock/dehydration related to severe diarrhea. CONCLUSIONS Bifidobacterium animalis subsp lactis and Lactobacillus rhamnosus had no effect on diarrhea in children with SAM during hospitalization, but reduced the number of days with diarrhea in outpatient treatment by 26%. Thank you
Single-Dose Azithromycin Versus Benzathine Benzylpenicillin For Treatment of Yaws in Children in Papua New Guinea: An Open-Label, Non-Inferiority, Randomised Trial